Health Condition 1: K87- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere
Conditions
Interventions
Intervention1: Administration of Intravenous Paracetamol for postoperative pain reduction.: To evaluate the clinical efficacy of 1g Intravenous Paracetamol for postoperative pain in patients undergoin
Sponsors
Heritage Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: ASA grade I/II patients, Age between 18-60 years scheduled for elective laparoscopic cholecystectomy
Exclusion criteria
Exclusion criteria: Patients who had history of allergy to paracetamol or tramadol, Patients with severe pain (VAS = 5), Patients with signi ?cant coronary artery disease or ischemic myocardial disease, Patients with renal disease , liver disease , chronic lung disease and haemorrhagic conditions and/or coagulopathies, Patients with history of addiction to opioids or alcohol, Patient’s refusal
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intravenous paracetamol provides better management in postoperative pain in patients undergoing laparoscopic cholecystectomy. Timepoint: Pain score before drug administration (T0), 30th minute (T1), 2nd hour (T2), 4th hour (T3), 8th hour (T4), 16th hour (T5), 24th hour (T6). Haemodynamic parameters at 0 minute, 30 minutes, 2 hr, 4 hr, 8 hr, 16 hr, 24 hr. | — |
Secondary
| Measure | Time frame |
|---|---|
| Intravenous paracetamol has lesser side effects as compared to intravenous tramadol. Timepoint: Haemodynamic parameters at 0 minute, 30 minutes, 2 hr, 4 hr, 8 hr, 16 hr, 24 hr. Prevalence of Adverse effects – Nausea, Vomiting, Dizziness, Drowsiness | — |
Countries
India
Contacts
Public ContactAkhilesh Mishra
Heritage Institute of Medical Sciences
Outcome results
None listed